Life sciences news
-
Mithra to receive EUR 2.5 million milestone payment from Fuji Pharma under ESTELLE® licensing agreement
Monday October 23rd 2023
Read more
-
Sequana Medical announces additional alfapump data supporting strong and durable clinical profile; PMA on track for year-end submission
Thursday October 19th 2023
Read more
-
Sequana Medical announces initial positive data from MOJAVE, a US Phase 1/2a study of DSR® 2.0 for treatment of heart failure through breaking vicious cycle of cardiorenal syndrome
Wednesday October 18th 2023
Read more
-
mRNA/LNP technology platform company etherna names Bernard Sagaert as Chief Executive Officer and Marijn Dekkers as Chairman of the Board
Tuesday October 17th 2023
Read more
-
Biocartis honors Breast Cancer Awareness Month with launch of Breast Cancer Portfolio
Monday October 16th 2023
Read more
-
Leuven researchers discover potential anti-cancer agents in diseased fish
Thursday October 12th 2023
Read more
-
Biocartis announces expansion of its collaboration with APIS Assay Technologies to commercialize the APIS ESR1 Mutations Kit
Thursday October 12th 2023
Read more
-
BioLizard launches new AI-empowered “BioVerse” platform to facilitate data-driven R&D for global life sciences community
Wednesday October 11th 2023
Read more
-
Become a flanders.bio member
Your news here?
-
Agomab raises $100 million Series C to advance fibrosis-focused pipeline
Wednesday October 11th 2023
Read more
-
SwiftPharma launches ODIN.AI: A groundbreaking AI-augmented antibody discovery platform
Monday October 9th 2023
Read more
-
Agomab receives FDA Fast Track Designation for AGMB-129 in Fibrostenosing Crohn’s Disease and starts STENOVA Phase 2a clinical trial
Friday October 6th 2023
Read more
More info?
Contact us
Ellen Telleir
Communication Coordinator
